cancer clinical trials in durham, NC
|
Duke University
Durham, North Carolina 27710 Breast Cancer
|
|
Duke University Medical Center
Durham, North Carolina 27710 Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
|
|
Duke University Medical Center
Durham, North Carolina 27710 Diffuse Large B-cell Lymphoma
|
|
Duke University Medical Center
Durham, North Carolina 27710 Pleural Effusion, Malignant
|
|
The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center
Durham, North Carolina 27710 Glioma
|
|
Duke University Medical Center
Durham, North Carolina 27710 Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
|
|
Duke University
Durham, North Carolina 27710 Cardiac Surgery, Erythrocyte Transfusion
|
|
Duke University Medical Center
Durham, North Carolina 27710 Multiple Myeloma
|
|
Duke University Health System
Durham, North Carolina 27705 Symptomatic Uterine Leiomyomas, Fibroids, Uterine Fibroids, Myomas
|
|
Duke University
Durham, North Carolina 27710 Breast Cancer
|
|
Duke Cancer Institute
Durham, North Carolina 27710 Lymphoma, Lymphoproliferative Disorder
|
|
The Preston Robert Tisch Brain Tumor Center at Duke
Durham, North Carolina 27710 Malignant Glioma, Glioblastoma Multiforme, Gliosarcoma
|
|
Duke University
Durham, North Carolina 27710 Severe Thalassemia
|
|
Duke University
Durham, North Carolina 27710 Refractory Cutaneous T-cell Lymphoma
|
|
Duke University Medical Center Dept. of DUMC (2)
Durham, North Carolina 27710 HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer
|
|
Duke University Medical Center
Durham, North Carolina 27710 Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
|
|
Duke Asthma Allergy and Airway Center
Durham, North Carolina 27704 Asthma
|
|
Duke University Medical Center
Durham, North Carolina 27710 Neuroblastoma
|
|
Duke University Medical Center Duke University Medical Ctr
Durham, North Carolina 27710 Hodgkin Lymphoma
|
|
Duke University Medical Center
Durham, North Carolina 27710 Multiple Myeloma
|
|
Duke University Medical Center
Durham, North Carolina 27710 Hematopoietic/Lymphoid Cancer, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Stage 0 Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage I Small Lymphocytic Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage III Small Lymphocytic Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Small Lymphocytic Lymphoma
|
|
Duke University Medical Center
Durham, North Carolina 27710 Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
|
|
Duke Univ. Med. Ctr. Adult CRS (1601)
Durham, North Carolina 27710 HIV Infections
|
|
Duke University
Durham, North Carolina 27710 Adverse Events, Usability Testing, Cognitive Testing
|
|
Duke University Medical Center
Durham, North Carolina 27710 Acute Myeloid Leukemia
|
|
Duke Comprehensive Cancer Center
Durham, North Carolina 27710 Fallopian Tube Cancer, Ovarian Cancer, Malignant Tumor of Peritoneum
|
|
Duke University Medical Center
Durham, North Carolina 27710 Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer
|
|
Duke University Medical Center - Cancer Prevention, Detection and Control
Durham, North Carolina 27710 Communication, Obesity, Nutrition, Physical Activity, Sleep
|
|
Duke University Medical Center
Durham, North Carolina 27710 Prostate Cancer
|
|
Duke University Medical Center
Durham, North Carolina 27710 Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
|
|
Veterans Affairs Medical Center - Durham
Trial Locations Veterans Affairs Medical Center - Durham Duke Cancer Institute Lung Cancer
|
|
Duke University Medical Center
Durham, North Carolina 27710 Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
|
|
Duke University Medical Center Dept. of DUMC (4)
Durham, North Carolina 27710 Relapsed or Refractory Multiple Myeloma
|
|
Duke University Medical Center
Durham, North Carolina 27710 Advanced Solid Tumors
|
|
Duke University Medical Center
Durham, North Carolina 27710 Lung Cancer
|
|
Duke University Medical Center
Durham, North Carolina 27710 Epithelial Ovarian Cancer
|
|
Duke University Medical Center
Durham, North Carolina 27710 Pancreatic Cancer
|
|
Duke University Medical Center
Durham, North Carolina 27710 Cancer, Solid Tumors, Lymphoma, Malignancy
|
|
Duke Cancer Institute
Durham, North Carolina 27710 Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
|
DUMC Division of Cellular Therapy/ABMT
Durham, North Carolina 27705 Multiple Myeloma
|
|
Duke University Medical Center
Durham, North Carolina 27710 Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
|
|
Investigational Site Number 840330
Durham, North Carolina 27710 Squamous Cell Lung Cancer
|
|
Duke University Medical Center Dept. of DUMC (4)
Durham, North Carolina 27710 Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Relapsed Multiple Myeloma
|
|
Duke Cancer Institute
Durham, North Carolina 27710 Malignant Mesothelioma
|
|
Duke University Medical Center
Durham, North Carolina 27710 Childhood Low-grade Cerebellar Astrocytoma, Childhood Low-grade Cerebral Astrocytoma, Childhood Mixed Glioma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Oligodendroglioma, Recurrent Childhood Visual Pathway and Hypothalamic Glioma, Recurrent Childhood Visual Pathway Glioma
|
|
Duke University Medical Center
Durham, North Carolina 27710 Ovarian Neoplasms, Breast Neoplasms, Prostatic Neoplasms
|
|
Duke Cancer Institute
Durham, North Carolina 27710 Cervical Cancer, Endometrial Cancer, Sarcoma
|
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Durham, North Carolina Head and Neck Neoplasms
|
|
Duke University Medical Center
Durham, North Carolina 27710 Chronic GVHD
|
|
Duke Univeristy Medical Center
Durham, North Carolina 27710 Advanced Non-clear Cell Renal Cell Carcinoma
|
|
Duke University Medical Center
Durham, North Carolina 27710 Multiple Myeloma
|
|
The Preston Robert Tisch Brain Tumor Center
Durham, North Carolina 27710 Glioblastoma Multiforme, Gliosarcoma
|
|
Duke University Medical Center
Durham, North Carolina 27710 Sickle Cell Disease, Vaso-occlusive Crisis, Pain Crisis
|
|
Duke University Medical Center
Durham, North Carolina 27710 Follicular Lymphoma, Marginal Zone Lymphoma
|
|
Site Reference ID/Investigator# 24922
Durham, North Carolina 27710 Gastric Cancer
|
|
Duke University Medical Center - The Preston Robert Tisch Brain Tumor Center
Durham, North Carolina 27710 Glioblastoma Multiforme, GBM, Gliosarcoma
|
|
Duke University Medical Center Duke - Baker
Durham, North Carolina 27710 Medulloblastoma,, Rhabdomyosarcoma,, Neuroblastoma,, Hepatoblastoma,, High Grade Glioma,, Astrocytoma
|
|
Duke University Medical Center
Durham, North Carolina 27710 Melanoma
|
|
Duke University Medical Center Duke South 2
Durham, North Carolina 27710 Metastatic Breast Cancer, Trastuzumab, BKM120, HER2+
|
|
Duke University Medical Center
Durham, North Carolina 27710 Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma
|
|
Battelle
Durham, North Carolina Multiple Myeloma, Leukemia, MGUS, MBL
|
|
Duke Cancer Institute
Durham, North Carolina 27710 Leukemia
|
|
Duke University Medical Center
Durham, North Carolina 27710 Male or Female Patients With a Serious or Immediately Life-threatening, Disease or Condition Caused by CMV, ADV, HSV, VAVC, VARV or, Monkeypox Viruses(s) Who Have a Life Expectancy of ≥ 2 Weeks and for, Whom no Comparable or Satisfactory Alternative Therapy is Available
|
|
Duke University Medical Center
Durham, North Carolina 27710 Pancreatic Adenocarcinoma
|
|
Duke University Medical Center
Durham, North Carolina 27710 Acute Myeloid Leukemia (AML)
|
|
Duke Cancer Institute
Durham, North Carolina 27710 Colorectal Cancer
|
|
Duke University Medical Center
Durham, North Carolina 27710 Liver Transplant Recipient
|
|
Novartis Investigative Site
Durham, North Carolina 27710 Neoplasm, Cancer, Tumors
|
|
Duke University Medical Center
Durham, North Carolina 27710 Psoriasis
|
|
Duke University Medical Center
Durham, North Carolina 27710 Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
|
|
Duke University Medical Center
Durham, North Carolina 27710 Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
|
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Durham, North Carolina Non Small Cell Lung Cancer
|
